Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990730 · ClinicalTrials.gov registry record
Atherosclerosis in Rheumatoid Arthritis
A clinical trial, sponsored by University of California, San Francisco.
- Completed
- Registry status
- 80
- Enrollment target
NCT00990730: Completed study, sponsored by University of California, San Francisco.
NCT00990730 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00990730 has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the link between rheumatoid arthritis and cardiovascular disease by studying inflammation, joint disease, cholesterol abnormalities, and endothelial function.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-06 |
What the finished NCT00990730 record still lists
NCT00990730 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00990730 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00990730 about?
NCT00990730 is a clinical study titled "Atherosclerosis in Rheumatoid Arthritis". The purpose of this study is to investigate the link between rheumatoid arthritis and cardiovascular disease by studying inflammation, joint disease, cholesterol abnormalities, and endothelial function.
What is the current status of trial NCT00990730?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2009-09. Estimated completion is 2011-06.
Who is sponsoring clinical trial NCT00990730?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia